Answers are grounded in this paper and cite their sources.
Objectives Accurate staging of oral squamous cell carcinoma (OSCC) is crucial for prognosis and treatment planning. This study evaluates clinical staging accuracy, identifies factors contributing to discrepancies, and examines their impact on survival, particularly with the rising role of neoadjuvant immunotherapy. Materials and methods A retrospective analysis of 545 OSCC patients assessed concordance between clinical and pathological staging. Logistic regression identified risk factors for misjudgment, while Kaplan-Meier curves and Cox proportional hazards models evaluated survival outcomes. Results T stage concordance was observed in 315 patients (57.79%), with 125 (22.93%) upstaged and 104 (19.08%) downstaged. N stage concordance occurred in 319 patients (58.53%), with 159 (29.17%) upstaged and 67 (12.29%) downstaged. The highest T stage concordance was seen in cT4a (76.55%) and cT1 (68.32%), while cN0 showed the highest N stage accuracy (74.21%). Histopathological factors, including grading, perineural invasion, and lymphatic invasion, were significantly associated with staging misjudgment. Both N-stage upstaging and downstaging were independently associated with worse overall survival, whereas T-stage discordance was not significantly associated with overall survival. Conclusions Significant discrepancies exist between clinical and pathological staging in OSCC. Histopathological features such as grading, perineural invasion, and lymphatic invasion were associated with staging discordance and may help identify patients at increased risk of clinical understaging. Clinical relevance These findings highlight the need for enhanced staging strategies to optimize patient outcomes.
No takes yet. Share an insight, caveat, or question.
Struckmeier et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: